Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/61207
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO’Connell, Jimen
dc.contributor.authorDoherty, Jayneen
dc.contributor.authorBuckley, Amyen
dc.contributor.authorCormican, Daviden
dc.contributor.authorDunne, Caraen
dc.contributor.authorHartery, Karenen
dc.contributor.authorLarkin, Johnen
dc.contributor.authorMacCarthy, Finbaren
dc.contributor.authorMcCormick, Paulen
dc.contributor.authorMcKiernan, Susanen
dc.contributor.authorMehigan, Brianen
dc.contributor.authorMuldoon, Cianen
dc.contributor.authorRyan, Ciaraen
dc.contributor.authorO’Sullivan, Jacinthaen
dc.contributor.authorKevans, Daviden
dc.date.accessioned2024-07-05T06:17:34Z-
dc.date.available2024-07-05T06:17:34Z-
dc.date.issued2022-
dc.identifier.citationIntestinal Research, 20(3), p. 381-385en
dc.identifier.issn2288-1956en
dc.identifier.issn1598-9100en
dc.identifier.urihttps://hdl.handle.net/1959.11/61207-
dc.description.abstract<p>Ulcerative colitis (UC) is a chronic relapsing remitting inflammatory disease of the colon. The lifetime risk of presentation with acute severe ulcerative colitis (ASUC) is 15%.<sup>1</sup> Patients with ASUC receive first line therapy with intravenous corticosteroids, however, approximately 30% have corticosteroid-refractory disease.<sup>2</sup>,3 In this situation, rescue medical therapy options include the anti-tumor necrosis factor (TNF) monoclonal antibody infliximab (IFX) or the calcineurin inhibitor ciclosporin.<sup>2</sup> A significant proportion of patients fail to respond to IFX therapy with reported colectomy rates at 1 year of 35%.<sup>4</sup> Biomarkers which identify patients with corticosteroid-refractory ASUC, with a reduced likelihood of IFX response, would significantly advance clinical care for these patients.</p>en
dc.languageenen
dc.publisherKorean Association for the Study of Intestinal Diseases,Daehan Jang Yeon'gu Haghoeen
dc.relation.ispartofIntestinal Researchen
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleColonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitisen
dc.typeJournal Articleen
dc.identifier.doi10.5217/ir.2021.00073en
dcterms.accessRightsUNE Greenen
local.contributor.firstnameJimen
local.contributor.firstnameJayneen
local.contributor.firstnameAmyen
local.contributor.firstnameDaviden
local.contributor.firstnameCaraen
local.contributor.firstnameKarenen
local.contributor.firstnameJohnen
local.contributor.firstnameFinbaren
local.contributor.firstnamePaulen
local.contributor.firstnameSusanen
local.contributor.firstnameBrianen
local.contributor.firstnameCianen
local.contributor.firstnameCiaraen
local.contributor.firstnameJacinthaen
local.contributor.firstnameDaviden
local.profile.schoolSchool of Healthen
local.profile.emailabuckl23@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeKorea, Republic ofen
local.format.startpage381en
local.format.endpage385en
local.peerreviewedYesen
local.identifier.volume20en
local.identifier.issue3en
local.access.fulltextYesen
local.contributor.lastnameO’Connellen
local.contributor.lastnameDohertyen
local.contributor.lastnameBuckleyen
local.contributor.lastnameCormicanen
local.contributor.lastnameDunneen
local.contributor.lastnameHarteryen
local.contributor.lastnameLarkinen
local.contributor.lastnameMacCarthyen
local.contributor.lastnameMcCormicken
local.contributor.lastnameMcKiernanen
local.contributor.lastnameMehiganen
local.contributor.lastnameMuldoonen
local.contributor.lastnameRyanen
local.contributor.lastnameO’Sullivanen
local.contributor.lastnameKevansen
dc.identifier.staffune-id:abuckl23en
local.profile.orcid0000-0002-5080-8580en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/61207en
local.date.onlineversion2022-
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleColonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitisen
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorO’Connell, Jimen
local.search.authorDoherty, Jayneen
local.search.authorBuckley, Amyen
local.search.authorCormican, Daviden
local.search.authorDunne, Caraen
local.search.authorHartery, Karenen
local.search.authorLarkin, Johnen
local.search.authorMacCarthy, Finbaren
local.search.authorMcCormick, Paulen
local.search.authorMcKiernan, Susanen
local.search.authorMehigan, Brianen
local.search.authorMuldoon, Cianen
local.search.authorRyan, Ciaraen
local.search.authorO’Sullivan, Jacinthaen
local.open.fileurlhttps://rune.une.edu.au/web/retrieve/5db9239c-8b09-49ae-8d29-6dab5af655acen
local.uneassociationNoen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.year.available2022en
local.year.published2022en
local.fileurl.openhttps://rune.une.edu.au/web/retrieve/5db9239c-8b09-49ae-8d29-6dab5af655acen
local.fileurl.openpublishedhttps://rune.une.edu.au/web/retrieve/5db9239c-8b09-49ae-8d29-6dab5af655acen
local.subject.for20203211 Oncology and carcinogenesisen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeUnknownen
Appears in Collections:Journal Article
School of Health
Files in This Item:
2 files
File Description SizeFormat 
openpublished/ColonicBuckley2022JournalArticle.pdfPublished version1.07 MBAdobe PDF
Download Adobe
View/Open
Show simple item record

SCOPUSTM   
Citations

1
checked on Jan 4, 2025

Page view(s)

186
checked on Aug 3, 2024

Download(s)

8
checked on Aug 3, 2024
Google Media

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons